JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Epistemonikos ID: b702979fb7e472da99d4d7c086e2616de29b389b
First added on: May 09, 2024